Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Liebman

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Hematology|July 27, 2010
What do healthcare providers ask their patients with immune thrombocytopenia?Daniel U Rabin, David J Kuter, Howard A Liebman, et al.
Blood|April 28, 2009
The ITP syndrome: pathogenic and clinical diversityDouglas B Cines, James B Bussel, Howard A Liebman, et al.
Autoimmunity Reviews|May 19, 2015
Management of immune-mediated cytopenias in pregnancyCaroline I Piatek, Ihab El-Hemaidi, Donald I Feinstein, et al.
The Journal of Rheumatology|February 9, 2006
Rituximab treatment for resistant antiphospholipid syndromeElyse Rubenstein, Daniel G Arkfeld, Samy Metyas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2006
Progressive prothrombotic state in women with advancing HIV diseaseAlexandra M Levine, Cheryl Vigen, Jay Gravink, et al.
Frontiers in Medicine|July 12, 2021
Understanding Immune Thrombocytopenia: Looking Out of the BoxAlexandra Schifferli, Franco Cavalli, Bertrand Godeau, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Journal of Vascular Surgery|June 3, 2008
Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopeniaTamas Alexy, Sonny Tucker, Soames Boyle, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Journal of Vascular Surgery|October 9, 2002
Anticoagulation is an effective treatment for aortic mural thrombiMichael E Bowdish, Fred A Weaver, Howard A Liebman, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Hematology|July 27, 2010
What do healthcare providers ask their patients with immune thrombocytopenia?Daniel U Rabin, David J Kuter, Howard A Liebman, et al.
Blood|April 28, 2009
The ITP syndrome: pathogenic and clinical diversityDouglas B Cines, James B Bussel, Howard A Liebman, et al.
Autoimmunity Reviews|May 19, 2015
Management of immune-mediated cytopenias in pregnancyCaroline I Piatek, Ihab El-Hemaidi, Donald I Feinstein, et al.
The Journal of Rheumatology|February 9, 2006
Rituximab treatment for resistant antiphospholipid syndromeElyse Rubenstein, Daniel G Arkfeld, Samy Metyas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 14, 2006
Progressive prothrombotic state in women with advancing HIV diseaseAlexandra M Levine, Cheryl Vigen, Jay Gravink, et al.
Frontiers in Medicine|July 12, 2021
Understanding Immune Thrombocytopenia: Looking Out of the BoxAlexandra Schifferli, Franco Cavalli, Bertrand Godeau, et al.
Acta Haematologica|October 31, 2019
A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic AnemiaCaroline I Piatek, Hillel Bocian, Sandra Algaze, et al.
Journal of Vascular Surgery|June 3, 2008
Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopeniaTamas Alexy, Sonny Tucker, Soames Boyle, et al.
Transfusion|May 20, 2015
Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximabMark Boonyasampant, Ilene C Weitz, Brian Kay, et al.
Journal of Vascular Surgery|October 9, 2002
Anticoagulation is an effective treatment for aortic mural thrombiMichael E Bowdish, Fred A Weaver, Howard A Liebman, et al.
Pageof 7